Ara
Toplam kayıt 7, listelenen: 1-7
Fibrinogen and D-dimer levels in prostate cancer: Preliminary results
(Elsevier B.V., 2017)
Background Prostate cancer is one of the most common malignancy in men. The main risk factors for coagulation activation and thrombosis are malignancy and older age. The thrombosis risk may be associated with increased ...
Does small prostate predict high grade prostate cancer?
(College of Physicians and Surgeons Pakistan, 2017)
Objective: The current is study aimed to assess the patients who underwent radical prostatectomy for prostate cancer and investigate the association between prostate size and adverse outcomes at final pathology. Study ...
Diagnostic efficacy of free prostate-specific antigen/total prostate-specific antigen ratio for the diagnosis of prostate cancer in low concentration (≤4 ng/ml) and intermediate levels of total prostate-specific antigen (4.01-10.0 ng/ml)
(Wolters Kluwer - Medknow, 2017)
Aim of Study: Serum prostate-specific antigen (PSA) is a useful tumor biomarker for prostate cancer (PCa) diagnosis. In this study, I aimed to compare the free/total PSA (fPSA%) with PSA alone for their usefulness in ...
Prevelance of prostate cancer among Turkish men with prostate-specific antigen level of ≤100 ng/ml
(Wolters Kluwer Medknow Publications, 2018)
Aim of Study: Prostate cancer (PCa) is one of the most common cancers among men and has become a significant health problem in developing and developed countries. Prostate-specific antigen (PSA) is a useful marker for ...
Awareness of prostate cancer diagnosis and management among Turkish males: a cross sectional study from Çorum
(Taylor and Francis Ltd, 2019)
Introduction: Prostate cancer is the most common malignancy among men in the United States and the second most common cancer in Turkey. The incidence of prostate cancer is increasing in industrialized countries. Aim: The ...
The clinical importance of percentage free prostate-specific antigen (PSA) in the PSA level of 4-20 ng/ml
(Kuwait Medical Association, 2018)
Objective: The current study aimed to evaluate the diagnostic efficacy of percentage free/total prostate-specific antigen ratio (%fPSA = free/total PSA*100) for prostate cancer diagnosis in different PSA levels (4.1 - 10 ...
Obesity is associated with upgrading in prostate cancers
(NLM (Medline), 2018)
BACKGROUND: Prostate cancer (PCa) is the second most common cancer and sixth most common cause of cancer associated death among men in the world. Multiple studies demonstrated the relationship between obesity and PCa in ...